Yoshihiro Nishida Selected Research

Aggressive Fibromatosis (Desmoid)

1/2022	Efficacy of auranofin as an inhibitor of desmoid progression.
11/2021	Trends in diagnostic and therapeutic strategies for extra-abdominal desmoid-type fibromatosis: Japanese musculoskeletal oncology group questionnaire survey.
11/2021	Efficacy and safety of cyclooxygenase 2 inhibitors for desmoid tumor management: a systematic review.
6/2021	A comparison of the usefulness of nuclear beta-catenin in the diagnosis of desmoid-type fibromatosis among commonly used anti-beta-catenin antibodies.
3/2021	[Ⅰ. Evidence-Based Drug Treatment for Desmoids-Anti-Cancer Drugs, Molecular-Targeted Drugs].
1/2021	The Prognostic Role of β-Catenin Mutations in Desmoid-type Fibromatosis Undergoing Resection Only: A Meta-analysis of Individual Patient Data.
11/2020	Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial.
10/2020	Effectiveness of doxorubicin-based and liposomal doxorubicin chemotherapies for patients with extra-abdominal desmoid-type fibromatosis: a systematic review.
9/2020	Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
9/2020	Is tumour location a prognostic factor for pharmacological treatment in patients with desmoid-type fibromatosis? a systematic review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshihiro Nishida Research Topics

Disease

73	Neoplasms (Cancer) 07/2022 - 07/2005
27	Aggressive Fibromatosis (Desmoid) 01/2022 - 07/2009
24	Neoplasm Metastasis (Metastasis) 04/2022 - 03/2006
18	Sarcoma (Soft Tissue Sarcoma) 04/2022 - 03/2008
16	Osteosarcoma (Osteogenic Sarcoma) 07/2021 - 07/2005
15	Fibroma (Fibromatosis) 01/2022 - 03/2010
9	Infections 07/2022 - 01/2007
8	Pain (Aches) 12/2021 - 02/2013
8	Wounds and Injuries (Trauma) 12/2018 - 01/2011
6	Margins of Excision 11/2020 - 11/2010
5	Neurofibrosarcoma (MPNST) 06/2022 - 01/2008
5	Chondrosarcoma 04/2022 - 05/2012
4	Giant Cell Tumor of Bone 09/2022 - 10/2007
4	Pneumonia (Pneumonitis) 01/2018 - 12/2015
3	Rhabdomyosarcoma 04/2022 - 01/2011
3	Vitamin D Deficiency 12/2021 - 01/2020
3	Necrosis 07/2021 - 01/2009
3	Osteoarthritis 03/2021 - 05/2004
3	Neutropenia 01/2021 - 01/2020
3	Carcinogenesis 01/2021 - 01/2009
3	Liposarcoma 05/2020 - 12/2019
3	Disease Progression 01/2020 - 07/2015
3	Paralysis (Palsy) 05/2017 - 12/2016
3	Spinal Cord Injuries (Spinal Cord Injury) 10/2016 - 11/2011
3	Carcinoma (Carcinomatosis) 06/2013 - 07/2006
2	Neurilemmoma (Schwannoma) 06/2022 - 01/2008
2	Hip Osteoarthritis (Coxarthrosis) 05/2022 - 11/2017
2	Osteonecrosis (Kienbock's Disease) 05/2022 - 04/2019
2	Experimental Arthritis 04/2022 - 05/2013
2	Arthritis (Polyarthritis) 04/2022 - 05/2013
2	Osteoporosis 12/2021 - 11/2016
2	Spontaneous Remission 08/2021 - 12/2018
2	Knee Osteoarthritis 01/2021 - 01/2021
2	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2013
2	Spinal Cord Neoplasms (Spinal Cord Tumors) 11/2019 - 01/2018
2	Stroke (Strokes) 08/2019 - 05/2019
2	Giant Cell Tumors (Giant Cell Tumor) 02/2019 - 01/2016
2	Surgical Wound Infection 11/2017 - 12/2015
2	Spinal Cord Diseases 06/2017 - 03/2017
2	Inflammation (Inflammations) 10/2016 - 05/2013
2	Pigmented Villonodular Synovitis 07/2015 - 01/2004

Drug/Important Bio-Agent (IBA)

16	Hyaluronic Acid (Hyaluronan)IBA 05/2022 - 05/2004
9	CateninsIBA 01/2021 - 01/2014
9	Meloxicam (Mobic)FDA LinkGeneric 12/2019 - 03/2006
7	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 11/2021 - 03/2006
6	Pharmaceutical PreparationsIBA 04/2022 - 03/2009
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 02/2013
6	Biological ProductsIBA 06/2018 - 03/2004
6	Proteins (Proteins, Gene)FDA Link 07/2015 - 09/2004
5	HymecromoneIBA 01/2018 - 01/2012
4	Denosumab FDA Link 09/2022 - 08/2018
4	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 04/2022 - 01/2017
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2021 - 11/2009
4	Messenger RNA (mRNA)IBA 07/2021 - 09/2004
4	pazopanib FDA Link 01/2021 - 05/2016
4	RNA (Ribonucleic Acid)IBA 02/2020 - 09/2004
3	Vitamin D FDA LinkGeneric 12/2021 - 01/2020
3	Diclofenac (SR 38)FDA LinkGeneric 03/2021 - 01/2021
3	diclofenac etalhyaluronateIBA 03/2021 - 01/2021
3	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 12/2015
3	Vinblastine (Vinblastine Sulfate)FDA Link 11/2020 - 12/2015
3	Ifosfamide FDA LinkGeneric 05/2020 - 02/2013
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2014
3	Matrix Metalloproteinases (MMPs)IBA 06/2014 - 01/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008 - 09/2004
2	Alcian BlueIBA 04/2022 - 01/2020
2	EnzymesIBA 07/2021 - 11/2011
2	Hyaluronan SynthasesIBA 07/2021 - 07/2005
2	Therapeutic UsesIBA 09/2020 - 01/2012
2	Phosphotransferases (Kinase)IBA 01/2020 - 10/2016
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2020 - 01/2017
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2018 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2018 - 07/2003
2	CarbonIBA 01/2018 - 01/2011
2	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2016 - 01/2016

Therapy/Procedure

22	Drug Therapy (Chemotherapy) 04/2022 - 11/2008
17	Therapeutics 09/2022 - 10/2006
11	Radiotherapy 04/2022 - 11/2010
7	Conservative Treatment 11/2021 - 02/2012
6	Curettage 09/2022 - 10/2007
6	Surgical Amputation (Amputations) 02/2022 - 04/2007
6	Limb Salvage 02/2022 - 03/2008
6	Operative Surgical Procedures 11/2020 - 01/2014
5	Activities of Daily Living (ADL) 11/2021 - 06/2006
4	Neoadjuvant Therapy 08/2021 - 01/2006
4	Decompression 11/2017 - 12/2016
3	Prostheses and Implants (Prosthesis) 07/2022 - 04/2014
3	Metastasectomy 01/2021 - 01/2016
3	Length of Stay 01/2019 - 01/2018
3	Laminoplasty 01/2018 - 06/2017
3	Adjuvant Chemotherapy 12/2014 - 01/2006
2	Molecular Targeted Therapy 01/2022 - 09/2012
2	Radiofrequency Ablation 01/2021 - 01/2016
2	Hepatectomy 05/2020 - 01/2019
2	Pancreaticoduodenectomy 05/2020 - 01/2019
2	Reoperation 04/2019 - 04/2014
2	Heavy Ion Radiotherapy 04/2019 - 01/2011
2	Spinal Fusion (Spondylosyndesis) 12/2018 - 01/2018
2	Osteotomy 01/2018 - 01/2017
2	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2018 - 01/2016